Is this you? Create Your Porfile
Avatar

Klaus Dr. Wirth

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Klaus Dr. Wirth is active.

Explore More

Publication

Featured researches published by Klaus Dr. Wirth.

Archive | 1994

Use of Bradykinin-antagonists for the manufacture of a medicament for the prophylaxis and treatment of arteriosclerosis

Wolfgang Dr. Linz; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Breipohl; Stephan Henke; Jochen Knolle

Archive | 1997

(Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Bernward Prof. Dr. Schölkens; Gerhard Nolken

Archive | 1993

Peptides with N-terminal modifications having bradykinin antagonistic activity

Gerhard Breipohl; Stephan Henke; Jochen Knolle; Bernward Prof. Dr. Schölkens; Hans-Georg Alpermann; Hermann Dr. Gerhards; Klaus Dr. Wirth

Archive | 1997

Use of non-peptide bradykinin antagonists for treating and preventing chronic fibrogenetic liver diseases, acute liver diseases and complications thereof

Holger Heitsch; Adalbert Wagner; Klaus Dr. Wirth; Max Hropot; Martin Bickel

Archive | 1997

Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists

Adalbert Wagner; Holger Heitsch; Gerhard Dr. Nölkne; Klaus Dr. Wirth; Bernard

Archive | 1997

Use of non-peptidic bradykinin antagonists in the preparation of medicaments for the treatment and prevention of Alzheimer's disease

Holger Heitsch; Gabriele Wiemer; Klaus Dr. Wirth

Archive | 1994

Use of bradykinin antagonists for the treatment of viral diseases

Fred Lembeck; Klaus Dr. Wirth; Irvin Winkler; Gerhard Breipohl; Stephan Henke; Jochen Knolle

Archive | 1996

New 1-(4-amino-benzyl)-pyrrolidine propionic acid derivatives

Adalert Dr Wagner; Gerhard Breipohl; Holger Heitsch; Hermann Dr. Gerhards; Gerhard Dr Noelken; Klaus Dr. Wirth; Bernward Prof Dr Schoelkens

Archive | 2004

Use of specific 2-substituted benzamides for treating and preventing cardiac insufficiency, especially where caused by diastolic dysfunction, act by inhibition of the Kv1.5 potassium channel

Klaus Dr. Wirth

Archive | 2004

Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them

Uwe Heinelt; Jochen-Hans Dr. Lang; Armin Hofmeister; Klaus Dr. Wirth; Hans-Willi Jansen

Explore More

Collaboration

Dive into the Klaus Dr. Wirth's collaboration.

Top Co-Authors
Avatar

Holger Heitsch

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Gerhard Breipohl

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Adalbert Wagner

Clariant

View shared research outputs
Top Co-Authors
Avatar

Jochen Knolle

Harvard University

View shared research outputs
Top Co-Authors
Avatar

Stephan Henke

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Fred Lembeck

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Irvin Winkler

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Joachim Brendel

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Uwe Heinelt

Case Western Reserve University

View shared research outputs
Top Co-Authors
Avatar

Armin Hofmeister

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge